Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ocuphire Pharma, Inc. | Director | Common Stock | 88.4K | $156K | $1.77 | Jun 11, 2024 | Direct |
Ocuphire Pharma, Inc. | Director | Stock Option (Right to Buy) | 35.2K | Jun 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCUP | Ocuphire Pharma, Inc. | Jun 11, 2024 | 2 | $0 | 4 | Jun 13, 2024 | Director |
OCUP | Ocuphire Pharma, Inc. | Jun 6, 2023 | 2 | $0 | 4 | Jun 8, 2023 | Director |
OCUP | Ocuphire Pharma, Inc. | Dec 31, 2022 | 1 | $0 | 5 | Feb 14, 2023 | Director |
OCUP | Ocuphire Pharma, Inc. | Oct 19, 2022 | 2 | $0.16 | 4 | Oct 20, 2022 | Director |
OCUP | Ocuphire Pharma, Inc. | Jun 13, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
OCUP | Ocuphire Pharma, Inc. | Dec 31, 2021 | 1 | $0 | 5 | Feb 14, 2022 | Director |
OCUP | Ocuphire Pharma, Inc. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |